Fluorescent- and gadolinium-labeled liposomes were prepared by the thin film hydration method. A rhodamine-labeled lipid (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt), DPPE-Rhodamine) and a gadolinium labeled lipid ((DTPA-bis(stearylamide) (gadolinium salt), Gd-DTPA-BSA) was used to incorporate rhodamine and gadolinium on the head groups of the lipid bilayer. The lipid composition was a molar ratio of 58.4-59.5 mol percent DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine), 35 mol percent Gd-DTPA-BSA, 5 mol percent DSPE-PEG2k (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N- [methoxy (polyethylene glycol)-2000] (ammonium salt)), and 0.5-1.6 mol percent DPPE-Rhodamine. Lipids were dissolved in a 2:1 volume ratio of chloroform:methanol which was evaporated over a stream of argon gas and left in a vacuum desiccator overnight to remove residual solvent. The lipid thin film was rehydrated with PBS for 2 hours at 66°C with occasional stirring and pipetting. The lipid solution was sonicated at 20% power for 2 min with a probe sonicator, and extruded sequentially through membrane filters with 1.0 um pores (4×), 0.4 um pores (6×), and 0.2 um pores (8×) to prepare liposomes with a mean diameter of 130-150 nm (Group B). To prepare liposomes with a mean diameter of 70-85 nm (Group A), the lipid solution was extruded in the same manner with additional extrusion through membrane filters with 0.1 um pores (8×), and 0.05 urn pores (12×). The size of the liposomes was measured by dynamic light scatterin. The administered dose was similar for group A (0.56±0.03 mmol total lipid/kg body weight) and group B (0.51±0.08 mmol total lipid/kg body weight). The calculated administered dose assumes no loss of lipid due to extrusion.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.